Key Highlights
- Mirador Therapeutics names Gregg Gilbert as new CFO
- Gregg brings over 25 years of biopharma equity research and investment banking experience
- Previously served as Managing Director at Bank of America Securities
- Focused on advancing Mirador’s precision therapies for immunology and inflammation
- Mirador raised over $400 million since its launch in 2024
Source: Business Wire
Notable Quotes
- “We are thrilled to welcome Gregg at this critical point in our company’s trajectory. Gregg’s impressive Wall Street experience bridges corporate and investor perspectives, and will be invaluable to guiding our next phase of growth.” — Mark C. McKenna, Chairman and CEO at Mirador Therapeutics
- “I am humbled to join this exceptionally talented and collaborative team as CFO, and look forward to making a meaningful impact as we work to deliver the next wave of precision medicines in I&I.” — Gregg Gilbert, CFO at Mirador Therapeutics
SoHC's Take
The appointment of Gregg Gilbert as CFO at Mirador Therapeutics signifies a strategic move to enhance its financial operations and investor relations as the company accelerates the development of next-generation precision therapies for immunology and inflammation. With over 25 years of experience advising biopharma companies and guiding capital strategies, Gregg’s leadership will be pivotal as Mirador transitions into its next growth phase. This appointment aligns with Mirador’s broader goal of rapidly building a diversified portfolio of transformational therapies.
Heading
Key Highlights Ginkgo Bioworks releases first proprietary protein LLM, trained on exclusive datasets.Collaboration with Google Cloud enables AI-driven drug discovery tools.Open API allows researchers to access Ginkgo’s machine ...
Key Highlights Courtney Green joins QGenda as Vice President of Nurse and Staff Solutions.Brings over 20 years of clinical and operational leadership experience.Focus on optimizing ...
Key Highlights Vyne Medical® acquires Extract Systems®, a leader in data extraction solutions.Accelerates healthcare automation by integrating AI and machine learning ...
Key Highlights PatientPay integrates with Azalea Health’s API to streamline patient billing for ambulatory providers.Faster revenue capture with less than 14 days to payment, ...
Key Highlights Partnership streamlines revenue cycle management for ABA therapy providers.Flychain’s financial tools offer real-time insights, secure funding, and automation.Raven ...
Key Highlights Nura Bio closes $140M Series A financing to support clinical development.Shilpa Sambashivan, Ph.D., appointed as CEO following Phase 1 success ...
